These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15607113)

  • 1. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world.
    Stefani M
    Biochim Biophys Acta; 2004 Dec; 1739(1):5-25. PubMed ID: 15607113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G; Verine J; Delpech M; Ries M
    Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What the use of disease-unrelated model proteins can tell us about the molecular basis of amyloid aggregation and toxicity.
    Stefani M
    Ital J Biochem; 2003 Dec; 52(4):162-76. PubMed ID: 15141483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.
    Stefani M; Dobson CM
    J Mol Med (Berl); 2003 Nov; 81(11):678-99. PubMed ID: 12942175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein misfolding, functional amyloid, and human disease.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2006; 75():333-66. PubMed ID: 16756495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastable, partially folded states in the productive folding and in the misfolding and amyloid aggregation of proteins.
    Ferreira ST; De Felice FG; Chapeaurouge A
    Cell Biochem Biophys; 2006; 44(3):539-48. PubMed ID: 16679542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic cell dysfunction in neurodegenerative disorders: role of surfaces in early protein misfolding, aggregation, and aggregate cytotoxicity.
    Stefani M
    Neuroscientist; 2007 Oct; 13(5):519-31. PubMed ID: 17901260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases.
    Bellotti V; Chiti F
    Curr Opin Struct Biol; 2008 Dec; 18(6):771-9. PubMed ID: 18952166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis of protein folding and its links with human disease.
    Dobson CM
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):133-45. PubMed ID: 11260793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological surfaces as catalysts of amyloid aggregate nucleation and primary sites of amyloid toxicity.
    Stefani M
    Ital J Biochem; 2006; 55(3-4):194-204. PubMed ID: 17274525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of amyloid-like aggregation as a driving force of protein evolution.
    Monsellier E; Chiti F
    EMBO Rep; 2007 Aug; 8(8):737-42. PubMed ID: 17668004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Evolution of Protein Sequences Able to Resist Self-Assembly to the Prediction of Aggregation Propensity.
    Bemporad F; Ramazzotti M
    Int Rev Cell Mol Biol; 2017; 329():1-47. PubMed ID: 28109326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the mechanisms of protein misfolding and aggregation in amyloidogenic diseases derived from pressure studies.
    Foguel D; Silva JL
    Biochemistry; 2004 Sep; 43(36):11361-70. PubMed ID: 15350123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.
    Stefani M
    Prog Neurobiol; 2012 Dec; 99(3):226-45. PubMed ID: 22450705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein folding and its links with human disease.
    Dobson CM
    Biochem Soc Symp; 2001; (68):1-26. PubMed ID: 11573341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selected aspects of amyloidogenesis].
    Stepkowski D
    Postepy Biochem; 2012; 58(1):110-4. PubMed ID: 23214135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.